Hi Mark Thanks, yes I've just had confirmation from our IT manager that there's a known bug in our Microsoft Exchange Server. Apparently in the case of some large attachments our server fails to send the acknowledgement of successful receipt to the sender even though the e-mail has been delivered successfully to my inbox, so the sender thinks it was undelivered & keeps trying 32 times! (i.e. 256 Mb of e-mails in this case!!!).
Thanks a lot for getting back to me! Cheers -- Ian > -----Original Message----- > From: Mark J. van Raaij [mailto:[email protected]] > Sent: 20 July 2009 10:35 > To: Ian Tickle > Subject: Re: [ccp4bb] Density for pyrophosphate? > > Dear Ian, > I got it only once, fortunately, so perhaps the multiplication was the > fault of a server at your end... > Mark > > > Mark J. van Raaij > Dpto de Bioquímica, Facultad de Farmacia > Universidad de Santiago > 15782 Santiago de Compostela > Spain > http://web.usc.es/~vanraaij/ > > > > > > > On 20 Jul 2009, at 09:57, Ian Tickle wrote: > > >> -----Original Message----- > >> From: [email protected] [mailto:owner- > >> [email protected]] > > On > >> Behalf Of Artem Evdokimov > >> Sent: 20 July 2009 03:12 > >> To: 'Junyu Xiao'; [email protected] > >> Subject: RE: [ccp4bb] Density for pyrophosphate? > > > >> Incidentally, if you compress the images you sent it's possible to > >> get > > the > >> size down from 3 MB each (encoded for email it's actually 4MB each!) > > down > >> to > >> about 60-100 KB each without significant loss of quality. I am sorry > > for > >> bringing up my pet peeve but not everyone on this list enjoys 8 MB > > mass > >> emails, especially when the contents do not justify the size in any > > way :) > >> > >> Artem > > > > In the same vein, has anyone else received SEVEN copies of Junyu's > > e-mail (each complete with 8Mb of attachments!) over the last ~7 hrs > > this morning - and who knows, there may be yet more in the > > pipeline! I > > appreciate that this multiplication of e-mails is probably not the > > fault > > of Junyu, I'm just reporting it so that those in charge of the server > > can investigate. > > > > Cheers > > > > -- Ian > > > > > > Disclaimer > > This communication is confidential and may contain privileged > > information intended solely for the named addressee(s). It may not > > be used or disclosed except for the purpose for which it has been > > sent. If you are not the intended recipient you must not review, > > use, disclose, copy, distribute or take any action in reliance upon > > it. If you have received this communication in error, please notify > > Astex Therapeutics Ltd by emailing [email protected] > > and destroy all copies of the message and any attached documents. > > Astex Therapeutics Ltd monitors, controls and protects all its > > messaging traffic in compliance with its corporate email policy. The > > Company accepts no liability or responsibility for any onward > > transmission or use of emails and attachments having left the Astex > > Therapeutics domain. Unless expressly stated, opinions in this > > message are those of the individual sender and not of Astex > > Therapeutics Ltd. The recipient should check this email and any > > attachments for the presence of computer viruses. Astex Therapeutics > > Ltd accepts no liability for damage caused by any virus transmitted > > by this email. E-mail is susceptible to data corruption, > > interception, unauthorized amendment, and tampering, Astex > > Therapeutics Ltd only send and receive e-mails on the basis that the > > Company is not liable for any such alteration or any consequences > > thereof. > > Astex Therapeutics Ltd., Registered in England at 436 Cambridge > > Science Park, Cambridge CB4 0QA under number 3751674 > Disclaimer This communication is confidential and may contain privileged information intended solely for the named addressee(s). It may not be used or disclosed except for the purpose for which it has been sent. If you are not the intended recipient you must not review, use, disclose, copy, distribute or take any action in reliance upon it. If you have received this communication in error, please notify Astex Therapeutics Ltd by emailing [email protected] and destroy all copies of the message and any attached documents. Astex Therapeutics Ltd monitors, controls and protects all its messaging traffic in compliance with its corporate email policy. The Company accepts no liability or responsibility for any onward transmission or use of emails and attachments having left the Astex Therapeutics domain. Unless expressly stated, opinions in this message are those of the individual sender and not of Astex Therapeutics Ltd. The recipient should check this email and any attachments for the presence of computer viruses. Astex Therapeutics Ltd accepts no liability for damage caused by any virus transmitted by this email. E-mail is susceptible to data corruption, interception, unauthorized amendment, and tampering, Astex Therapeutics Ltd only send and receive e-mails on the basis that the Company is not liable for any such alteration or any consequences thereof. Astex Therapeutics Ltd., Registered in England at 436 Cambridge Science Park, Cambridge CB4 0QA under number 3751674
